Silver: The Undercover Super Metal Does Medicine, Too

The Next Move in Junior Miners May Be Closer Than It Appears
Source: John Newell (04/09/2026)

John Newell of John Newell & Associates explains his thoughts on the current junior miners market and shares some stocks that might be worth looking into.

read more >

Gold-Silver Project Moves Into Critical Test Phase as 2027 Resource Target Takes Shape
Source: Streetwise Reports (04/09/2026)

Sun Summit Minerals Corp. (SMN:TSX.V; SMREF:OTCQB) has launched metallurgical testing at its JD Project, targeting gold and silver recovery across key zones.

read more >

Canadian Biotech Co. Appoints Elite Regulatory Expert for Chile Expansion
Source: Streetwise Reports (04/08/2026)

MindBio Therapeutics Corp. (MBIO:CSE; MBQIF:OTCQB; WF6:Frankfurt) appoints Chilean policy leader Felipe Leyton for the mining rollout of its AI impairment detection tech.

read more >

California Biotech Co. Advances Depression Drug Breakthrough
Source: Streetwise Reports (04/07/2026)

Alto Neuroscience Inc. (ANRO:NYSE) pivots after mixed trial results, targeting treatment-resistant depression with analyst support and major market growth potential.

read more >

San Francisco Pharma Co.'s HORIZON Phase 2 Data Validates APOL1 Path to Pivotal Trial
Source: Dr. Ananda Ghosh (04/07/2026)

H.C. Wainwright reiterated its rating and price target on Maze Therapeutics (MAZE:NASDAQ), following KOL calls that validated the HORIZON Phase 2 dataset as biologically coherent, confirmed the diabetic cohort signal as drug-attributable proof of concept, and outlined a clear path to pivotal trials.

read more >